Publications by authors named "Lars Kjerpeseth"

Claim this Profile
N
Nationwide Trends in Incidence of Stroke and Transient Ischemic Attack in Younger and Older Adults in Norway 2001 to 2021.
Elisabeth Kvalvaag, Vidar Hjellvik, Lars Kjerpeseth, Jannicke Igland, Hanne Ellekjær

J Am Heart Assoc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of stroke risk reassessment in atrial fibrillation patients with a CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study.
Mariam Anjum, Inger Ariansen, Marius Myrstad, Lars J Kjerpeseth, Vidar Hjellvik

Europace· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairs.
Adrienne Y L Chan, Le Gao, Miyuki Hsing-Chun Hsieh, Lars J Kjerpeseth, Raquel Avelar

Nat Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy.
Carolyn E Cesta, Ran Rotem, Brian T Bateman, Gabriel Chodick, Jacqueline M Cohen, Lars J Kjerpeseth

JAMA Intern Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
Mariam Anjum, Inger Ariansen, Vidar Hjellvik, Randi Selmer, Lars J Kjerpeseth

Eur Heart J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and treatment of gestational diabetes in Norway 2010-2020.
Lars J Kjerpeseth, Vidar Hjellvik, Hanne L Gulseth, Øystein Karlstad, Paz Lopez-Doriga Ruiz

Diabetes Res Clin Pract· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy.
Jacqueline M Cohen, Silje Alvestad, Elizabeth A Suarez, Andrea Schaffer, Randi M Selmer, Lars J Kjerpeseth

Neurology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin Versus Insulin and Risk of Major Congenital Malformations in Pregnancies With Type 2 Diabetes: A Nordic Register-Based Cohort Study.
Lars J Kjerpeseth, Carolyn E Cesta, Kari Furu, Anders Engeland, Mika Gissler

Diabetes Care· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
Joris J Komen, Anton Pottegård, Aukje K Mantel-Teeuwisse, Tomas Forslund, Paul Hjemdahl, Lars J Kjerpeseth

Eur Heart J· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Incidence Rates of Atrial Fibrillation in Denmark 2004-2018.
Emilie R Hegelund, Lars J Kjerpeseth, Laust H Mortensen, Jannicke Igland, Trygve Berge

Clin Epidemiol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using multiple random index dates with the reverse waiting time distribution improves precision of estimated prescription durations.
Katrine Bødkergaard, Randi Marie Selmer, Jesper Hallas, Lars Jøran Kjerpeseth, Eva Skovlund

Pharmacoepidemiol Drug Saf· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries.
Joris J Komen, Anton Pottegård, Aukje K Mantel-Teeuwisse, Tomas Forslund, Paul Hjemdahl, Lars J Kjerpeseth

Europace· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and incidence rates of atrial fibrillation in Norway 2004-2014.
Lars Jøran Kjerpeseth, Jannicke Igland, Randi Selmer, Hanne Ellekjær, Arnljot Tveit

Heart· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using the waiting time distribution with random index dates to estimate prescription durations in the presence of seasonal stockpiling.
Katrine Bødkergaard, Randi M Selmer, Jesper Hallas, Lars J Kjerpeseth, Anton Pottegård

Pharmacoepidemiol Drug Saf· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study.
Lars J Kjerpeseth, Randi Selmer, Inger Ariansen, Øystein Karlstad, Hanne Ellekjær

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation.
Lars J Kjerpeseth, Hanne Ellekjær, Randi Selmer, Inger Ariansen, Kari Furu

Eur J Clin Pharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015.
Lars J Kjerpeseth, Hanne Ellekjær, Randi Selmer, Inger Ariansen, Kari Furu

Eur J Clin Pharmacol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leflunomide inhibition of BK virus replication in renal tubular epithelial cells.
Eva Bernhoff, Garth D Tylden, Lars J Kjerpeseth, Tore J Gutteberg, Hans H Hirsch

J Virol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis